234 related articles for article (PubMed ID: 30917379)
1. Retrospective Analysis to Determine the Optimal Timing to Discontinue Continuous Antibiotic Prophylaxis in Patients with Primary Vesicoureteral Reflux.
Anraku T; Obara K; Tasaki M; Tomita Y
Urol Int; 2019; 102(4):462-467. PubMed ID: 30917379
[TBL] [Abstract][Full Text] [Related]
2. Girls and renal scarring as risk factors for febrile urinary tract infection after stopping antibiotic prophylaxis in children with vesicoureteral reflux.
Nakamura M; Moriya K; Kon M; Nishimura Y; Chiba H; Kitta T; Shinohara N
World J Urol; 2021 Jul; 39(7):2587-2595. PubMed ID: 33388912
[TBL] [Abstract][Full Text] [Related]
3. Susceptibility of the Index Urinary Tract Infection to Prophylactic Antibiotics Is a Predictive Factor of Breakthrough Urinary Tract Infection in Children with Primary Vesicoureteral Reflux Receiving Continuous Antibiotic Prophylaxis.
Lee JN; Byeon KH; Woo MJ; Baek HS; Cho MH; Jeong SY; Lee SM; Ham JY; Ha YS; Kim HT; Yoo ES; Kwon TG; Chung SK
J Korean Med Sci; 2019 Jun; 34(21):e156. PubMed ID: 31144480
[TBL] [Abstract][Full Text] [Related]
4. Risk Factors for Recurrent Urinary Tract Infection and Renal Scarring.
Keren R; Shaikh N; Pohl H; Gravens-Mueller L; Ivanova A; Zaoutis L; Patel M; deBerardinis R; Parker A; Bhatnagar S; Haralam MA; Pope M; Kearney D; Sprague B; Barrera R; Viteri B; Egigueron M; Shah N; Hoberman A
Pediatrics; 2015 Jul; 136(1):e13-21. PubMed ID: 26055855
[TBL] [Abstract][Full Text] [Related]
5. Impact of continuous low-dose antibiotic prophylaxis on growth in children with vesicoureteral reflux.
Guidos PJ; Arlen AM; Leong T; Bonnett MA; Cooper CS
J Pediatr Urol; 2018 Aug; 14(4):325.e1-325.e7. PubMed ID: 30181099
[TBL] [Abstract][Full Text] [Related]
6. Computer model predicting breakthrough febrile urinary tract infection in children with primary vesicoureteral reflux.
Arlen AM; Alexander SE; Wald M; Cooper CS
J Pediatr Urol; 2016 Oct; 12(5):288.e1-288.e5. PubMed ID: 27072485
[TBL] [Abstract][Full Text] [Related]
7. The Swedish infant high-grade reflux trial: UTI and renal damage.
Nordenström J; Sjöström S; Sillén U; Sixt R; Brandström P
J Pediatr Urol; 2017 Apr; 13(2):146-154. PubMed ID: 28215835
[TBL] [Abstract][Full Text] [Related]
8. Continuous antibiotic prophylaxis reduces the risk of febrile UTI in children with asymptomatic antenatal hydronephrosis with either ureteral dilation, high-grade vesicoureteral reflux, or ureterovesical junction obstruction.
Herz D; Merguerian P; McQuiston L
J Pediatr Urol; 2014 Aug; 10(4):650-4. PubMed ID: 25155409
[TBL] [Abstract][Full Text] [Related]
9. Contemporary Management of Vesicoureteral Reflux.
Hajiyev P; Burgu B
Eur Urol Focus; 2017 Apr; 3(2-3):181-188. PubMed ID: 28918954
[TBL] [Abstract][Full Text] [Related]
10. The Swedish infant high-grade reflux trial: Study presentation and vesicoureteral reflux outcome.
Nordenström J; Holmdahl G; Brandström P; Sixt R; Stokland E; Sillén U; Sjöström S
J Pediatr Urol; 2017 Apr; 13(2):130-138. PubMed ID: 27889221
[TBL] [Abstract][Full Text] [Related]
11. Treatment of occult reflux lowers the incidence rate of pediatric febrile urinary tract infection.
Hagerty J; Maizels M; Kirsch A; Liu D; Afshar K; Bukowski T; Caione P; Homsy Y; Meyer T; Kaplan W;
Urology; 2008 Jul; 72(1):72-6. PubMed ID: 18407331
[TBL] [Abstract][Full Text] [Related]
12. Long-term incidence of febrile UTI after DxHA treatment of VUR.
Fotso Kamdem A; Galli G; Aubert D
J Pediatr Urol; 2014 Feb; 10(1):56-61. PubMed ID: 23810062
[TBL] [Abstract][Full Text] [Related]
13. Bacterial pathogens in first febrile urinary tract infection affect breakthrough infections in infants with vesicoureteral reflux treated with prophylactic antibiotics.
Park S; Song SH; Lee C; Kim JW; Kim KS
Urology; 2013 Jun; 81(6):1342-5. PubMed ID: 23562584
[TBL] [Abstract][Full Text] [Related]
14. Outcome of antibiotic prophylaxis discontinuation in patients with persistent vesicoureteral reflux initially presenting with febrile urinary tract infection: time to event analysis.
Leslie B; Moore K; Salle JL; Khoury AE; Cook A; Braga LH; Bägli DJ; Lorenzo AJ
J Urol; 2010 Sep; 184(3):1093-8. PubMed ID: 20650501
[TBL] [Abstract][Full Text] [Related]
15. The impact of obesity on febrile urinary tract infection and renal scarring in children with vesicoureteral reflux.
Byun HJ; Ha JY; Jung W; Kim BH; Park CH; Kim CI
J Pediatr Urol; 2017 Feb; 13(1):67.e1-67.e6. PubMed ID: 28087230
[TBL] [Abstract][Full Text] [Related]
16. Vesicoureteral reflux and continuous prophylactic antibiotics.
Lee T; Park JM
Investig Clin Urol; 2017 Jun; 58(Suppl 1):S32-S37. PubMed ID: 28612058
[TBL] [Abstract][Full Text] [Related]
17. Observation of patients with vesicoureteral reflux off antibiotic prophylaxis: physician bias on patient selection and risk factors for recurrent febrile urinary tract infection.
Drzewiecki BA; Thomas JC; Pope JC; Adams MC; Brock JW; Tanaka ST
J Urol; 2012 Oct; 188(4 Suppl):1480-4. PubMed ID: 22906676
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial prophylaxis for children with vesicoureteral reflux.
; Hoberman A; Greenfield SP; Mattoo TK; Keren R; Mathews R; Pohl HG; Kropp BP; Skoog SJ; Nelson CP; Moxey-Mims M; Chesney RW; Carpenter MA
N Engl J Med; 2014 Jun; 370(25):2367-76. PubMed ID: 24795142
[TBL] [Abstract][Full Text] [Related]
19. Top-down approach is possible strategy for predicting breakthrough fUTIs and renal scars in infants.
Kawai S; Kanai T; Hyuga T; Nakamura S; Aoyagi J; Ito T; Saito T; Odaka J; Furukawa R; Aihara T; Nakai H
Pediatr Int; 2017 Jul; 59(7):781-785. PubMed ID: 28370971
[TBL] [Abstract][Full Text] [Related]
20. Early discontinuation of antibiotic prophylaxis in patients with persistent primary vesicoureteral reflux initially detected during infancy: outcome analysis and risk factors for febrile urinary tract infection.
Moriya K; Mitsui T; Kitta T; Nakamura M; Kanno Y; Kon M; Nishimura Y; Shinohara N; Nonomura K
J Urol; 2015 Feb; 193(2):637-42. PubMed ID: 25111912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
